MJFF Targets to Therapies: Mitochondrial Target Validation
Supports mitochondrial target validation in Parkinson's research to build stronger therapy-ready evidence.
The Michael J. Fox Foundation Targets to Therapies: Mitochondrial Target Validation program is a two-stage competitive grant designed to build a robust evidence base for mitochondrial targets with high potential relevance to Parkinson's disease. MJFF, which has committed over $2 billion to PD research and is one of the world's largest private funders in the field, structured this program around fu…
Funds target modulation, human relevance evidence, mechanism clarification, biomarker identification, and safety characterization for mitochondrial targets with high potential relevance to Parkinson's disease.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Write proposalGrant Concept Note Example: Pre-Proposal Structure for Startups
See a practical grant concept note example, with a worked deeptech pre-proposal, section map, invite-to-full logic, and reviewer checks.
BudgetBudget Narrative Example for Grant Proposals
See how to write a grant budget narrative with line-item examples, a template structure, weak vs strong wording, and reviewer-facing cost logic.
More from MJFF
All grants from this funder →MJFF Therapeutics Pipeline Program — Pre-Proposals
MJFF · United States
Supports Parkinson's disease research teams in the MJFF Therapeutics Pipeline with sustained coaching toward therapeutic candidate development.
Edmond J. Safra Fellowship in Movement Disorders — Class of
MJFF · United States
Offers long-form fellowship support for movement disorder physicians and researchers in global academic centers.
MJFF Access Advocate for Clinical Research Participation
🇺🇸MJFF · United States
Supports structured trial access advocacy in Parkinson's programs by strengthening participant pathways at sites.
MJFF GBA1 Parkinson's Disease Research Catalyst Program
MJFF · United States
Connects United States Parkinson's researchers through the MJFF GBA1 Catalyst Program for precision treatment design and testing.
MJFF Parkinson's Disease Proteoforms Program
MJFF · United States
Funds proteoform-focused Parkinson's research to strengthen molecular evidence and translational targets.
Similar grants
Browse the directory →
Cancer Mission: Functional Genomics for New Treatments
🇪🇺European Commission · European Union
Funds €7–8M projects that use functional genomics and patient data to uncover precise new targets for difficult-to-treat cancers.
NIH SBIR — Receipt (First Post-Reauthorization
🇺🇸NIH · United States
Supports United States. small businesses moving vision innovation from feasibility to development.
NIH STTR — Receipt (First Post-Reauthorization
🇺🇸NIH · United States
Supports small businesses partnering with research institutions on collaborative development pathways.
Grand Solutions Grant
🇩🇰Innovationsfonden · Denmark
Funds Denmark-wide flagship consortia tackling difficult science and engineering problems through shared-stage support.
NIDA SBIR/STTR
🇺🇸NIDA · United States
Supports United States. small businesses advancing drug abuse intervention and treatment technologies.
NCATS STTR Phase II
🇺🇸NCATS · United States
Funds U.S. small businesses and their nonprofit research partners to continue and expand translational R&D begun in STTR Phase I toward a commercial product.